Reduction of asymmetric dimethylarginine involved in the cardioprotective effect of losartan in spontaneously hypertensive rats

Canadian Journal of Physiology and Pharmacology

Volumn 85, Issue 8, 2007, Pages 783-789

  Li, Dai ^a   Xia, Ke ^a   Li, Nian Sheng ^a   Luo, Dan ^a   Wang, Shan ^a   Jiang, De Jian ^a   Deng, Han Wu ^a   Li, Yuan Jian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Asymmetric dimethylarginine; Ischemia; Losartan; Reperfusion; Spontaneously hypertensive rat

Indexed keywords

ACETYLCHOLINE; ARGININE DERIVATIVE; CREATINE KINASE; DIMETHYLARGININE; LOSARTAN; NITRIC OXIDE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; ENZYME ACTIVITY; ENZYME RELEASE; ESSENTIAL HYPERTENSION; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE INJURY; HEART PERFUSION; HEART PROTECTION; HEART RATE; ISCHEMIA; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR RING; WISTAR KYOTO RAT;

ANIMALS; ARGININE; BLOOD PRESSURE; HYPERTENSION; LOSARTAN; MALE; NITRIC OXIDE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; VASODILATION;

EID: 36348976903     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y07-073     Document Type: Article

References (26)

1. Alderman, M.H., Madhavan, S., Ooi, W.L., Cohen, H., Sealey, J.E., and Laragh, J.H. 1991. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N. Engl. J. Med. 324: 1098-1104.
2. Benter, I.F., Francis, I., Khan, I., Cojocel, C., Juggi, J.S., Yousif, M.H., Canatan, H., and Akhtar, S. 2005. Signal transduction involving Ras-GTPase contributes to development of hypertension and end-organ damage in spontaneously hypertensive rats-treated with L-NAME. Pharmacol. Res. 52: 401-412. doi:10.1016/j.phrs.2005.06.001.
3. Chen, M.F., Xie, X.M., Yang, T.L., Wang, Y.J., Zhang, X.H., Luo, B.L., and Li, Y.J. 2007. Role of Asymmetric Dimethylarginine in Inflammatory Reactions by Angiotensin II. J. Vasc. Res. 44: 391-402. doi:10.1159/000103284.
4. De Gusmao, F.M., Becker, C., Carvalho, M.H., and Barros, L.F. 2005. Angiotensin II inhibition during myocardial ischemia-reperfusion in dogs: effects on leukocyte infiltration, nitric oxide synthase isoenzymes activity and left ventricular ejection fraction. Int. J. Cardiol. 100: 363-370. doi:10.1016/j.ijcard.2004.03.017.
5. Di Napoli, P., Taccardi, A.A., Grilli, A., De Lutiis, M.A., Barsotti, A., Felaco, M., and De Caterina, R. 2005. Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts. Cardiovasc. Res. 66: 462-471. doi:10.1016/j. cardiores.2005.02.008.
6. Feng, Q., Lu, X., Jones, D.L., Shen, J., and Arnold, J.M. 2001. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation, 104: 700-704.
7. Fleetwood, G., Boutinet, S., Meier, M., and Wood, J.M. 1991. Involvement of the renin-angiotensin system in ischemic damage and reperfusion arrhy thmias in the isolated perfused rat heart. J. Cardiovasc. Pharmacol. 17: 351-356.
8. Hammoud, T., Tanguay, J.F., and Bourassa, M.G. 2000. Management of coronary artery disease: therapeutic options in patients with diabetes. J. Am. Coll. Cardiol. 36: 355-365. doi:10.1016/S0735-1097(00)00732-4.
9. Hoshida, S., Yamashita, N., Kawahara, K., Kuzuya, T., and Hori, M. 1999. Amelioration by quinapril of myocardial infarction induced by coronary occlusion/reperfusion in a rabbit model of atherosclerosis: possible mechanisms. Circulation, 99: 434-440.
10. Ito, A., Egashira, K., Narishige, T., Muramatsu, K., and Takeshita, A. 2001. Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension. Jpn. Circ. J. 65: 775-778. doi:10.1253/jcj.65.775.
11. Jia, S.J., Jiang, D.J., Hu, C.P., Zhang, X.H., Deng, H.W., and Li, Y.J. 2006. Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells. Vascul. Pharmacol. 44: 143-148. doi:10.1016/j.vph.2005.09.005.
12. Jiang, J.L., Zhu, H.Q., Chen, Z., Xu, H.Y., and Li, Y.J. 2005. Angiotensin-converting enzyme inhibitors prevent LDL-induced endothelial dysfunction by reduction of asymmetric dimethylarginine level. Int. J. Cardiol. 101: 153-155. doi:10.1016/j.ijcard.2004.01.006.
13. Johnstone, M.T., Creager, S.J., Scales, K.M., Cusco, J.A., Lee, B.K., and Creager, M.A. 1993. Impaired nitric oxide-mediated vasodilation inpatients with non-insulin-dependent diabetes mellitus. Circulation, 88: 2510-2516.
14. Kielstein, J.T., Bogor, R.H., Bode-Boger, S.M., Schaffer, J., Barbey, M., Koch, K.M., and Frolich, J.C. 1999. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J. Am. Soc. Nephrol. 10: 594-600.
15. Lee, Y.M., Peng, Y.Y., Ding, Y.A., and Yen, M.H. 1997. Losartan attenuates myocardial ischemia-induced ventricular arrythmias and reperfusion injury in spontaneously hypertensive rats. Am. J. Hypertens. 10: 852-858. doi:10.1016/S0895-7061(97)00119-2.
16. Murry, C.E., Jennings, R.B., and Reimer, K.A. 1986. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 74: 1124-1136.
17. Olafsson, B., Forman, M.B., Puett, D.W., Pou, A., Catesm, C.U., Friesingerm, G.C., and Virmani, R. 1987. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. Circulation, 76: 1135-1145.
18. Oudot, A., Vergely, C., Ecarnot-Laubriet, A., and Rochette, L. 2003. Angiotensin II activates NADPH oxidase in isolated rat hearts subjected to ischaemia-reperfusion. Eur. J. Pharmacol. 462: 145-154. doi:10.1016/S0014-2999(03)01315-3.
19. Panza, J.A., Quyyumi, A.A., Brush, J.E., Jr., and Epstein, S.E. 1990. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N. Engl. J. Med. 323: 22-27.
20. Paz, Y., Gurevitch, J., Frolkis, I., Matsa, M., Kramer, A., Locker, C., Mohr, R., and Keren, G. 1998. Effects of an angiotensin II antagonist on ischemic and nonischemic isolated rat hearts. Ann. Thorac. Surg. 65: 474-479. doi:10.1016/S0003-4975(97)01234-4.
21. 1) receptor antagonist on the endothelial dysfunction in spontaneously hypertensive rats in correlation with the nitric oxide system. Bratisl. Lek. Listy, 104: 342-346.
22. Stuhlinger, M.C., Conci, E., Haubner, B.J., Stocker, E.M., Schwaighofer, J., Cooke, J.P., et al. 2007. Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury. Cardiovasc. Res. 75: 417-425. doi:10.1016/j.cardiores.2007.04.030.
23. Tang, W.J., Hu, C.P., Chen, M.F., Deng, P.Y., and Li, Y.J. 2006. Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level. Can. J. Physiol. Pharmacol. 84: 163-171. doi:10.1139/y05-156.
24. Vallance, P., Leone, A., Calver, A., Collier, J., and Moncada, S. 1992. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet, 339: 572-575. doi:10.1016/0140-6736(92)90865-Z.
25. Watt, P.A., and Thurston, H. 1989. Endothelium-dependent relaxation in resistance vessels from the spontaneously hypertensive rats. J. Hypertens. 7: 661-666. doi:10.1097/00004872-198908000-00010.
26. Zhou, F.W., Li, Y.J., Lu, R., and Deng, H.W. 1999. Protection of calcitonin gene-related peptide-mediated preconditioning against coronary endothelial dysfunction induced by reperfusion in the isolated rat heart. Life Sci. 64: 1091-1097. doi:10.1016/S0024-3205(99)00037-5.